Injections of N-methyl-D-aspartate into the ventral hippocampus increase extracellular dopamine in the ventral tegmental area and nucleus accumbens.
about
Romantic love: a mammalian brain system for mate choiceGlutamate Decarboxylase 67 Deficiency in a Subset of GABAergic Neurons Induces Schizophrenia-Related PhenotypesA neurobiological basis for substance abuse comorbidity in schizophreniaCocaine serves as a peripheral interoceptive conditioned stimulus for central glutamate and dopamine releaseDopamine D2 Modulation of Sign and Goal Tracking in RatsIron deficiency with or without anemia impairs prepulse inhibition of the startle reflex.Stem cell-derived interneuron transplants as a treatment for schizophrenia: preclinical validation in a rodent modelNovelty-evoked elevations of nucleus accumbens dopamine: dependence on impulse flow from the ventral subiculum and glutamatergic neurotransmission in the ventral tegmental area.Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders.A ventral tegmental CRF-glutamate-dopamine interaction in addiction.Hormones and Neuropeptide Receptor Heteromers in the Ventral Tegmental Area. Targets for the Treatment of Loss of Control of Food Intake and Substance Use DisordersHippocampal dysfunction and disruption of dopamine system regulation in an animal model of schizophrenia.Increased hippocampal CA1 cerebral blood volume in schizophrenia.Developmental pathology, dopamine, stress and schizophrenia.Latent inhibition-related dopaminergic responses in the nucleus accumbens are disrupted following neonatal transient inactivation of the ventral subiculum.Roles for nigrostriatal--not just mesocorticolimbic--dopamine in reward and addiction.Differentiating the rapid actions of cocaine.Hippocampal dysregulation of dopamine system function and the pathophysiology of schizophrenia.Orexin-corticotropin-releasing factor receptor heteromers in the ventral tegmental area as targets for cocaineDopaminergic regulation of limbic-striatal interplay.Heroin self-administration experience establishes control of ventral tegmental glutamate release by stress and environmental stimuli.Uncovering the role of the nucleus accumbens in schizophrenia: A postmortem analysis of tyrosine hydroxylase and vesicular glutamate transporters.Acetylcholine release in the mesocorticolimbic dopamine system during cocaine seeking: conditioned and unconditioned contributions to reward and motivation.Conditioned contribution of peripheral cocaine actions to cocaine reward and cocaine-seekingDifferential effects of acute and repeated stress on hippocampus and amygdala inputs to the nucleus accumbens shell.Ventral tegmental glutamate: a role in stress-, cue-, and cocaine-induced reinstatement of cocaine-seeking.Reinstatement of cocaine seeking by hypocretin (orexin) in the ventral tegmental area: independence from the local corticotropin-releasing factor networkFunctional implications of glutamatergic projections to the ventral tegmental area.Neural correlates of change in major depressive disorder anhedonia following open-label ketamine.Magnetic resonance imaging in studying schizophrenia, negative symptoms, and the glutamate system.Cell-based therapies for the treatment of schizophrenia.Role of the bed nucleus of the stria terminalis in the control of ventral tegmental area dopamine neurons.Context-specific activation of hippocampus and SN/VTA by reward is related to enhanced long-term memory for embedded objects.Functional μ-Opioid-Galanin Receptor Heteromers in the Ventral Tegmental Area.Amphetamine activation of hippocampal drive of mesolimbic dopamine neurons: a mechanism of behavioral sensitization.The hippocampus modulates dopamine neuron responsivity by regulating the intensity of phasic neuron activation.Phytocannabinoids modulate emotional memory processing through interactions with the ventral hippocampus and mesolimbic dopamine system: implications for neuropsychiatric pathology.Tyrosine hydroxylase localization in the nucleus accumbens in schizophrenia.Re-exposure to morphine-associated context facilitated long-term potentiation in the vSUB-NAc glutamatergic pathway via GluN2B-containing receptor activation.Human striatal response to reward anticipation linked to hippocampal glutamate levels.
P2860
Q24675930-FA8E29FE-D094-44E6-88FA-C1C710C64F22Q27310915-FD472679-94AE-4951-A176-3D64CB96D0A4Q28347063-844084CF-871D-4FFE-A447-5C23371C8F3EQ28473219-426BF96C-5B94-4F72-B595-9CE7A0653053Q30377905-5687A042-5799-4030-9669-FDCB4C1E6B8DQ30429665-C26B58E8-439E-4C5A-B973-07346CAB75D0Q30837351-40D6EFD7-91CE-4019-86F3-0D7A92182D86Q32027963-B519FADA-6C81-41E6-8882-D99F381FA25FQ33555684-B4D8D9AF-4DEC-4132-A386-313D660792BFQ33643410-A5863457-E13E-41B1-9469-C8E8572037FCQ33689876-2C9B8D6C-12E9-40FD-AFE7-9FEF07AF6E45Q33889886-FF7951B6-E3B8-41ED-A8FA-52BF487BD6F1Q34079242-5608A8BC-5445-477E-A69C-657BBEF66E82Q34500539-58FC1648-64A5-4629-8002-B148FE530EA8Q34988421-3CE559F8-1BB5-4823-95C6-A8CECEF6965DQ35003324-AE618306-2C67-45D7-9E55-3FF278891CBFQ35161471-3344B7F9-54EF-4406-98A4-D415423A0DB7Q35175354-0802E0DA-29B6-4FF7-9DAF-BD56F1CD20DFQ35547856-7229C8AB-825F-4194-AFA2-7DE7ACFF13AFQ36141814-3133D4E2-1027-4E44-BBD4-DF1D0BC8A6C2Q36403823-85C2040C-F25D-42F1-BBF0-BE034351C7D4Q36584724-8724D9B4-4F02-44AC-AC20-8F55900C8640Q36924849-BBFAA0C2-6B39-42F3-8AF4-1A025C5374F3Q37030171-BA578941-F313-44E1-93A0-F707E0AB980AQ37136319-044D9724-C484-4F85-861C-30AC4C649B76Q37206384-686DDCB8-B51F-49B0-BBF4-44CE4EC24EEFQ37250738-6DBFA9DB-9A68-481E-9BB7-6D86B52E604EQ37327514-696B8A4D-A494-438A-8BBC-26798616FCDCQ37424327-12246607-9776-420F-A3D6-E64868C3B2D0Q38207021-C9F4D8A3-E648-48E4-A9B6-9602DE149FD2Q38932809-0BBF8548-7DD1-4EAD-85C3-C63B1F287242Q40084832-425D5A02-1FF6-4AB3-A391-82CB47FAE9D7Q41260855-B308D361-BD63-4773-A724-5B5321787F3DQ41843746-CF9EAE05-7E9A-48F7-91BB-7651AFFE6F94Q41911596-EA39DA69-4150-4667-B5FC-E3D70D34B2B0Q46829207-0D4866FF-A079-4B94-A0D1-4FFD8AD60609Q48139337-3D9017D6-37E4-493A-A8AF-507333DE0E0DQ49032517-6E360B45-87F6-4C87-BE76-198A4872464DQ49116848-71A392D4-9C5E-4FDB-8B95-7AE5EAD955E4Q49999078-47F65BAF-0209-496F-942C-81BBD55E4590
P2860
Injections of N-methyl-D-aspartate into the ventral hippocampus increase extracellular dopamine in the ventral tegmental area and nucleus accumbens.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Injections of N-methyl-D-aspar ...... al area and nucleus accumbens.
@en
Injections of N-methyl-D-aspar ...... al area and nucleus accumbens.
@nl
type
label
Injections of N-methyl-D-aspar ...... al area and nucleus accumbens.
@en
Injections of N-methyl-D-aspar ...... al area and nucleus accumbens.
@nl
prefLabel
Injections of N-methyl-D-aspar ...... al area and nucleus accumbens.
@en
Injections of N-methyl-D-aspar ...... al area and nucleus accumbens.
@nl
P2860
P1433
P1476
Injections of N-methyl-D-aspar ...... al area and nucleus accumbens.
@en
P2093
P2860
P304
P356
10.1002/(SICI)1098-2396(19990315)31:4<241::AID-SYN1>3.0.CO;2-#
P577
1999-03-01T00:00:00Z